Apremilast, an Oral PDE4 Inhibitor, is associated with Long-Term (52-week) Improvement in Swollen/Tender Joint Counts in Psoriatic Arthritis Patients: Results of 3 Phase 3 Randomized Controlled Trials

  • PARK WON
제목
Apremilast, an Oral PDE4 Inhibitor, is associated with Long-Term (52-week) Improvement in Swollen/Tender Joint Counts in Psoriatic Arthritis Patients: Results of 3 Phase 3 Randomized Controlled Trials
저자
PARK WON
학회명
대한 류마티스학회 제35차 춘계학술대회 및 제9차 국제심포지엄
학회 개최일
2015-05-15 ~ 2015-05-16